{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:12:16Z","timestamp":1782522736510,"version":"3.54.5"},"reference-count":30,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In China, the optimal management of individuals living with chronic HBV infection (CHB) remains an unmet need. The EVOLVE Study was a 5-year prospective, longitudinal, observational study that compared the clinical outcomes in treatment-naive CHB patients receiving entecavir (ETV) or lamivudine (LAM)-based therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Males or females aged \u226518 years, diagnosed with CHB regardless of cirrhosis or hepatitis B e antigen (HBeAg) status were enrolled from tier 2 city hospitals (between 2012\u20132014). The choice of initial therapy and subsequent treatment modifications was at the discretion of treating physicians. Key outcomes included treatment modifications, virological response (HBV DNA &lt;300 copies\/ml) and HBV disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 3,408 patients enrolled, 1,807 and 628 received ETV and LAM-based therapy, respectively. The mean age was 39.5 years, 74% were male and 22.9% had cirrhosis. The rate of treatment modification was higher in the LAM-based versus ETV group (25.9% versus 13.7%); viral breakthrough was the most common reason in the LAM-based group versus financial reasons in the ETV group. At week 240, the virological response rate was 73% in both treatment groups. Compared with LAM-based therapy, ETV was associated with a significantly lower incidence of viral breakthrough (12.6% versus 2.1%) and genotypic resistance (10.1% versus 1.2%; P&lt;0.0001 for both); significantly lower risk of HBV disease progression (14.0% versus 10.7%; P=0.0113); and lower rates of progression to decompensated cirrhosis (9.6% versus 6.4%) and hepatocellular carcinoma (1.9% versus 0.8%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This real-world, longitudinal study demonstrated a significantly lower risk of HBV-related disease progression, viral breakthrough and resistance with ETV versus LAM-based therapy. ClinicalTrials.gov NCT01726439.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3851\/imp3372","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T12:23:12Z","timestamp":1603369392000},"page":"293-304","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-Term Outcomes in Chinese Patients with Chronic Hepatitis B Receiving Nucleoside\/Nucleotide Analogue Therapy in Real-World Clinical Practice: 5-Year Results from the EVOLVE Study"],"prefix":"10.1177","volume":"25","author":[{"given":"Jidong","family":"Jia","sequence":"first","affiliation":[{"name":"Beijing Friendship Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shang","sequence":"additional","affiliation":[{"name":"Henan Provincial People's Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaji","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ning","sequence":"additional","affiliation":[{"name":"Affiliated Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Dou","sequence":"additional","affiliation":[{"name":"Shengjing Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatology Hospital of Jilin, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Sixth People's Hospital of Shenyang, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[{"name":"Tianjin Third Central Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Tan","sequence":"additional","affiliation":[{"name":"Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Xijing Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Chen","sequence":"additional","affiliation":[{"name":"Xiamen Chinese Medical Hospital, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifang","family":"Sheng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Su","sequence":"additional","affiliation":[{"name":"The First Hospital of Quanzhou, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Chen","sequence":"additional","affiliation":[{"name":"Jinhua Central Hospital, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhei","family":"Dai","sequence":"additional","affiliation":[{"name":"The Fifth Hospital of Shijiazhuang, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Ye","sequence":"additional","affiliation":[{"name":"The First People's Hospital of Foshan, Foshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[{"name":"Taiyuan The Third People's Hospital, Taiyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Shen","sequence":"additional","affiliation":[{"name":"The First People's Hospital of Xiaoshan District, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"The Third People's Hospital of Shenzhen, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wei","sequence":"additional","affiliation":[{"name":"GCP ClinPlus Co., Ltd, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EVOLVE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"bibr1-IMP3372","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.219469"},{"key":"bibr2-IMP3372","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00218-2"},{"key":"bibr3-IMP3372","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161477"},{"key":"bibr4-IMP3372","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12990"},{"key":"bibr5-IMP3372","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26180"},{"key":"bibr6-IMP3372","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"bibr7-IMP3372","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051287"},{"key":"bibr8-IMP3372","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.007"},{"issue":"4","key":"bibr9-IMP3372","first-page":"619A","volume":"58","author":"Jia J H.J.","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"bibr10-IMP3372","volume":"18","author":"Kong Y.","year":"2017","journal-title":"International Clinical Trials Methodology Conference: Trials"},{"key":"bibr11-IMP3372","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5984-6"},{"key":"bibr12-IMP3372","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30056-6"},{"key":"bibr13-IMP3372","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3205"},{"key":"bibr14-IMP3372","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22138"},{"key":"bibr15-IMP3372","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12115"},{"key":"bibr16-IMP3372","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.45"},{"key":"bibr17-IMP3372","author":"Hou J.L.","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bibr18-IMP3372","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000815"},{"key":"bibr19-IMP3372","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.213969"},{"key":"bibr20-IMP3372","first-page":"13","volume":"19","author":"Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"bibr21-IMP3372","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.903382"},{"key":"bibr22-IMP3372","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.020"},{"key":"bibr23-IMP3372","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2009.00375.x"},{"key":"bibr24-IMP3372","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033364"},{"key":"bibr25-IMP3372","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.033"},{"key":"bibr26-IMP3372","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S98200"},{"key":"bibr27-IMP3372","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.51"},{"key":"bibr28-IMP3372","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S185120"},{"key":"bibr29-IMP3372","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3775-9"},{"key":"bibr30-IMP3372","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26301"}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3372","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3851\/IMP3372","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:52:57Z","timestamp":1777380777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3851\/IMP3372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.3851\/IMP3372"],"URL":"https:\/\/doi.org\/10.3851\/imp3372","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}